share_log

Merit Medical Systems, Inc. (NASDAQ:MMSI) Short Interest Down 9.9% in September

Merit Medical Systems, Inc. (NASDAQ:MMSI) Short Interest Down 9.9% in September

优点医疗系统公司(纳斯达克:MMSI)空头股数9月份下跌9.9%
Financial News Live ·  2022/10/02 09:51

Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating) was the recipient of a large drop in short interest in the month of September. As of September 15th, there was short interest totalling 964,500 shares, a drop of 9.9% from the August 31st total of 1,070,000 shares. Approximately 1.7% of the company's shares are sold short. Based on an average trading volume of 353,700 shares, the short-interest ratio is presently 2.7 days.

优点医疗系统公司(纳斯达克:MMSI-GET评级)是9月份空头股数大幅下跌的接受者。截至9月15日,空头股数共有96.45万股,较8月31日的107万股下降了9.9%。该公司约1.7%的股票被卖空。以平均成交量35.37万股计算,目前短息比率为2.7天。

Wall Street Analyst Weigh In

华尔街分析师也加入进来

Several brokerages recently weighed in on MMSI. TheStreet raised shares of Merit Medical Systems from a "c+" rating to a "b-" rating in a research report on Friday, September 16th. Piper Sandler lowered their price target on shares of Merit Medical Systems from $75.00 to $70.00 in a report on Friday, July 1st. StockNews.com lowered shares of Merit Medical Systems from a "strong-buy" rating to a "buy" rating in a research note on Wednesday. Canaccord Genuity Group lifted their price objective on shares of Merit Medical Systems from $67.00 to $69.00 and gave the company a "buy" rating in a research note on Friday, September 2nd. Finally, Canaccord Genuity Group lifted their price objective on shares of Merit Medical Systems from $67.00 to $69.00 in a research note on Friday, September 2nd. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $72.14.

几家券商最近也加入了对MMSI的看法。华尔街在9月16日星期五的一份研究报告中将Merit Medical Systems的股票评级从“c+”上调至“b-”。派珀·桑德勒在7月1日星期五的一份报告中将他们对Merit Medical Systems的目标股价从75.00美元下调至70.00美元。在周三的一份研究报告中,StockNews.com将Merit Medical Systems的股票评级从“强力买入”下调至“买入”。Cancord Genuity Group在9月2日星期五的一份研究报告中将Merit Medical Systems的股票目标价从67.00美元上调至69.00美元,并给予该公司“买入”评级。最后,在9月2日星期五的一份研究报告中,Canaccel Genuity Group将Merit Medical Systems的股票目标价从67.00美元上调至69.00美元。一名投资分析师对该股的评级为持有,六名分析师对该公司股票的评级为买入。根据MarketBeat.com的数据,该公司的平均评级为“适度买入”,共识目标价为72.14美元。

Get
到达
Merit Medical Systems
优点医疗系统
alerts:
警报:

Merit Medical Systems Stock Performance

优点医疗系统股票表现

Shares of NASDAQ:MMSI opened at $56.51 on Friday. The company has a market cap of $3.21 billion, a price-to-earnings ratio of 55.40, a price-to-earnings-growth ratio of 2.20 and a beta of 1.00. The company has a 50-day moving average price of $58.83 and a 200-day moving average price of $59.69. The company has a current ratio of 2.52, a quick ratio of 1.33 and a debt-to-equity ratio of 0.22. Merit Medical Systems has a 12 month low of $50.46 and a 12 month high of $73.44.

纳斯达克:MMSI上周五开盘报56.51美元。该公司市值为32.1亿美元,市盈率为55.40倍,市盈率为2.20倍,贝塔系数为1.00。该公司的50日移动均线价格为58.83美元,200日移动均线价格为59.69美元。该公司的流动比率为2.52,速动比率为1.33,债务权益比率为0.22。优点医疗系统公司的12个月低点为50.46美元,12个月高位为73.44美元。

Merit Medical Systems (NASDAQ:MMSI – Get Rating) last issued its quarterly earnings data on Wednesday, July 27th. The medical instruments supplier reported $0.73 EPS for the quarter, beating the consensus estimate of $0.58 by $0.15. Merit Medical Systems had a net margin of 5.24% and a return on equity of 13.74%. The firm had revenue of $294.98 million during the quarter, compared to the consensus estimate of $280.55 million. During the same period in the prior year, the firm posted $0.62 earnings per share. The company's quarterly revenue was up 5.2% compared to the same quarter last year. As a group, equities analysts anticipate that Merit Medical Systems will post 2.47 EPS for the current year.
优点医疗系统公司(纳斯达克:MMSI-GET评级)最近一次发布季度收益数据是在7月27日星期三。这家医疗器械供应商公布本季度每股收益为0.73美元,比普遍预期的0.58美元高出0.15美元。优点医疗系统公司的净利润率为5.24%,股本回报率为13.74%。该公司本季度营收为2.9498亿美元,而市场普遍预期为2.8055亿美元。去年同期,该公司公布的每股收益为0.62美元。与去年同期相比,该公司季度收入增长了5.2%。股票分析师预计,作为一个整体,Merit Medical Systems本年度的每股收益将达到2.47美元。

Insiders Place Their Bets

内部人士下注

In other Merit Medical Systems news, COO Neil Peterson sold 4,000 shares of the stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $58.10, for a total transaction of $232,400.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, COO Ronald Frost sold 20,000 shares of the firm's stock in a transaction dated Wednesday, August 10th. The stock was sold at an average price of $62.10, for a total value of $1,242,000.00. Following the completion of the sale, the chief operating officer now directly owns 15,144 shares in the company, valued at approximately $940,442.40. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Neil Peterson sold 4,000 shares of the firm's stock in a transaction dated Monday, August 1st. The shares were sold at an average price of $58.10, for a total value of $232,400.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 26,436 shares of company stock worth $1,627,142. Company insiders own 3.80% of the company's stock.

在Merit Medical Systems的其他消息中,首席运营官尼尔·彼得森在8月1日星期一的交易中出售了4000股该公司股票。该股以58.10美元的平均价格出售,总成交金额为232,400.00美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可以通过此超链接。在其他新闻方面,首席运营官罗纳德·弗罗斯特在8月10日星期三的一笔交易中出售了2万股该公司股票。这只股票的平均售价为62.10美元,总价值为1242,000.00美元。出售完成后,首席运营官现在直接拥有公司15,144股,价值约940,442.40美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过这个环节。此外,首席运营官尼尔·彼得森在一笔日期为8月1日星期一的交易中出售了4000股该公司股票。这些股票的平均价格为58.10美元,总价值为232,400.00美元。关于这次销售的披露可以找到这里。在过去的90天里,内部人士卖出了26,436股公司股票,价值1,627,142美元。公司内部人士持有该公司3.80%的股份。

Institutional Investors Weigh In On Merit Medical Systems

机构投资者看好Merit医疗系统

A number of hedge funds and other institutional investors have recently bought and sold shares of MMSI. Lindbrook Capital LLC grew its holdings in shares of Merit Medical Systems by 148.4% during the second quarter. Lindbrook Capital LLC now owns 477 shares of the medical instruments supplier's stock valued at $26,000 after buying an additional 285 shares during the last quarter. Meeder Asset Management Inc. purchased a new stake in shares of Merit Medical Systems during the first quarter valued at approximately $29,000. Harel Insurance Investments & Financial Services Ltd. purchased a new stake in shares of Merit Medical Systems during the second quarter valued at approximately $37,000. Quantbot Technologies LP purchased a new stake in shares of Merit Medical Systems during the first quarter valued at approximately $43,000. Finally, First Horizon Advisors Inc. grew its holdings in shares of Merit Medical Systems by 56.2% during the second quarter. First Horizon Advisors Inc. now owns 1,287 shares of the medical instruments supplier's stock valued at $70,000 after buying an additional 463 shares during the last quarter. Hedge funds and other institutional investors own 94.52% of the company's stock.

一些对冲基金和其他机构投资者最近买卖了MMSI的股票。Lindbrook Capital LLC在第二季度增持了148.4%的Merit Medical Systems股票。Lindbrook Capital LLC现在持有这家医疗器械供应商477股股票,价值2.6万美元,上个季度又购买了285股。Meeder资产管理公司在第一季度购买了价值约2.9万美元的Merit医疗系统公司的新股份。哈雷尔保险投资和金融服务有限公司在第二季度购买了价值约3.7万美元的Merit医疗系统公司的新股份。Quantbot Technologies LP在第一季度购买了价值约4.3万美元的Merit医疗系统公司的新股份。最后,First Horizon Advisors Inc.在第二季度增持了56.2%的Merit Medical Systems股票。First Horizon Advisors Inc.现在持有这家医疗器械供应商1,287股股票,价值7万美元,此前该公司在上个季度又购买了463股。对冲基金和其他机构投资者持有该公司94.52%的股票。

Merit Medical Systems Company Profile

优点医疗系统公司简介

(Get Rating)

(获取评级)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.

优点医疗系统公司设计、开发、制造和营销用于介入、诊断和治疗程序的一次性医疗产品,主要用于心脏病学、放射学、肿瘤学、危重护理和内窥镜检查。该公司在心血管和内窥镜两个领域开展业务。

Further Reading

进一步阅读

  • Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
  • EV Battery Maker Freyr Set For Major Global Expansion
  • MarketBeat: Week in Review 9/26 – 9/30
  • This Is A Memorable Time To Buy Into Micron Technology
  • Declining Profits Challenge the CarMax Value Proposition
  • Let Paychex Stock Work Hard For You
  • 免费获取StockNews.com关于Merit Medical Systems(MMSI)的研究报告
  • 电动汽车电池制造商Freyr将在全球大举扩张
  • MarketBeat:回顾一周9/26-9/30
  • 这是买入美光科技的难忘时刻
  • 利润下降对CarMax价值主张的挑战
  • 让Paychex股票为您努力工作

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

接受新闻和评级的优点医疗系统每日-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Merit Medical Systems和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发